Company intelligence / Profile preview

Treatwell

Ownership: Private
Employees: ~7
Development stage: Other

Overview

Treatwell Biotech is an Indian pharmaceutical manufacturer and marketer with a broad commercial portfolio of DCGI-approved drugs. Their products are manufactured in WHO-GMP certified facilities and cover a wide range of therapeutic areas including anti-inflammatories, antibiotics, vitamins/minerals/supplements and more[1][3][9]. No clinical trial data is reported; all products are approved generics or supplements.

Therapeutic areas: Metabolic DisordersNeurologyInfectious DiseasesHematologyEndocrinologyGastroenterologyImmunologyRheumatology
Modalities: Small moleculeProteinHormone replacement therapyVitamin supplementNutraceuticalsProbioticVitaminMineral supplement
Industry: Biotech

Beyond the preview

Go deeper on Treatwell.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Treatwell.

Explore the full profile